Top 5 Bioinformatics companies in San Jose, California, United States
Meet companies that are not just market leaders but change makers.
Top 7 Bioinformatics companies in Cambridge, Massachusetts, United States
Introducing the torchbearers of this industry, titans of tradition and pioneers of progress.
NextCODE Health
NextCODE Health is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. Using technology developed over more than 16 years at deCODE genetics, we are enabling the widespread incorporation of genome sequence data into patient diagnosis and care. NextCODE was acquired by WuXi AppTec in 2015 and was renamed WuXi NextCODE before rebranding to [Genuity Science](/organization/genuity-science) in 2020.
MetaCell
MetaCell applications and services advance our understanding of the brain. MetaCell software unlocks the true value of neuroscience data and models, including microscopy and MRI images, EEG and electrophysiology data, biologically accurate simulations, and much more.
Claritas Genomics
Claritas Genomics is a new venture, formed through a partnership between Boston Children's Hospital and Life Technologies Corp. Claritas develops next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced instrumentation, software and bioinformatics capabilities with sophisticated clinical interpretation by specialist physicians and medical genomics experts at Boston Children’s Hospital, a Harvard teaching hospital and the top-ranked pediatric hospital in the US.
kbDNA Inc.
kbDNA enables research laboratories by providing cutting-edge nucleotide synthesis and recombination solutions
Blueprint Medicines
Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat. Founded in 2011 by a proven team of scientists and entrepreneurs with world-renowned expertise in the development of targeted cancer therapies, cancer genomics, and rational drug development, Blueprint Medicines is poised to realize the promise of the cancer data revolution: truly personalized therapies that improve outcomes and shift cancer to a manageable condition.
Neon Therapeutics
Neon Therapeutics is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Expansion Technologies
Expansion Technologies pioneers the development of the expansion microscopy bioimaging tool to bring simple scalable nanoimaging to biology and medicine.
_files/webflow-badge-icon.f67cd735e3.svg){kind=icon}
_files/webflow-badge-text.6faa6a38cd.svg){kind=icon}